| Literature DB >> 22973831 |
Marielle Karine Bouyou-Akotet1, Denise Patricia Mawili-Mboumba, Eric Kendjo, Ariane Eyang Ekouma, Omar Abdou Raouf, Edouard Engohang Allogho, Maryvonne Kombila.
Abstract
BACKGROUND: Although a substantial decline of Plasmodium falciparum infection is observed in Africa following implementation of new control strategies, malaria is still considered as the major cause of febrile illness in hospitalized African children. The present study was designed to assess the management of febrile illness and to determine the proportion of children with febrile illness hospitalized for primary diagnosis of malaria who had confirmed complicated malaria after implementation of new malaria control strategies in Libreville, Gabon.Entities:
Mesh:
Year: 2012 PMID: 22973831 PMCID: PMC3520876 DOI: 10.1186/1471-2334-12-216
Source DB: PubMed Journal: BMC Infect Dis ISSN: 1471-2334 Impact factor: 3.090
Hospital recorded diagnosis based on patient clinical features
| Age in months, | 24.0 | [12–48] |
| Duration of illness in days | 3.0 | [2–5] |
| Temperature in °C | 38.9 | [38.0-39.3] |
| | ||
| Female | 192 | (46) |
| Pallor | 211 | (51) |
| Asthenia | 193 | (46) |
| Repeated vomiting | 151 | (36) |
| Diarrhoea | 120 | (29) |
| Abdominal pain | 32 | (8) |
| Cough | 118 | (28) |
| Dyspnea | 32 | (8) |
| Seizures | 73 | (17) |
| Blantyre Coma Score < 5 | 62 | (15) |
| Cough | 91 | (53) |
| Rattling | 79 | (46) |
| Deep breathing | 14 | (8) |
| Pneumonia syndrome | 40 | (23) |
| Abnormal x-ray | 151 | (88) |
| Vomiting | 63 | (85) |
| Dehydratation | 65 | (88) |
| Diarrhoea | 67 | (90) |
| Vomiting | 6 | (38) |
| BCS ≤ 4 | 8 | (50) |
| Seizures | 7 | (44) |
| Neck stiffness | 7 | (44) |
| Abnormal CSFb | 5/7 | (71) |
a: cases can appears in many categories; b: cerebro-spinald fluid.
Figure 1Distribution of main fever-attributable etiologies among children admitted for primary diagnosis of malaria.
Relationship between studied variables* and infection
| 48 [24–72] | 18 [9–36] | <0.01 | |
| 3 [2–4] | 4 [2–6] | <0.01 | |
| 39.0 [38.5-39.8] | 38.8 [38–39] | <0.01 | |
| | | | |
| - Hb, g/dL | 7.7 [5.8-9.7] | 9.5 [7.3-10.5] | <0.01 |
| - Leucocytes, 103/μL | 9.9 [7.1-12] | 12.0 [8.7-18.0] | <0.01 |
| - Platelets count, 103/μL | 89.0 [51.0-122.0] | 298.0 [165.0-417.0] | <0.01 |
*: medians with interquartile ranges are presented.
Logistic regression analysis of factors associated with risk of complicated malaria
| Age | | | | | |
| - ≥ 5 years (n = 86) | 32 (37.2%) | 2.6[1.5-4.3] | <0.01 | 2.5[1.3-4.7] | <0.01 |
| - < 5 years (n = 332) | 63 (19.0%) | 1 | | | |
| Bed net | | | | | |
| - users (n = 276) | 47 (17.0%) | 0.4[0.2-0.6] | <0.01 | 0.4[0.2-0.7] | <0.01 |
| - non users (n = 129 | 44 (34.1%) | 1 | | | |
| Drug intake | | | | | |
| -Yes | 41 (43.2%) | 0.5[0.3-0.8] | <0.01 | 1.3[0.8-2.3] | 0.3 |
| -No | 93 (28.8%) | 1 | | | |
| Pallor | | | | | |
| -Yes (n = 95) | 66 (69.5%) | 2.8[1.7-4.0] | <0.01 | 2.9[1.7-5.2] | <0.01 |
| -No (n = 321) | 143 (44.5%) | 1 | | | |
| Prostration | | | | | |
| -Yes (n = 95) | 18 (18.9%) | 2.3[1.2-4.3] | <0.01 | 3.6[0.0-40.8] | 0.3 |
| -No (n = 323) | 30 (9.3%) | 1 | | | |
| Neurological symptoms | | | | | |
| -Yes (n = 95) | 39 (41.0%) | 3.2[1.9-5.2] | <0.01 | 3.4[1.9-6.3] | <0.01 |
| -No (n = 323) | 60 (18.6%) | 1 | | | |
| Anaemia | | | | | |
| -Yes (n = 95) | 86 (90.5%) | 3.2[1.3-7.7] | <0.01 | 3.3[1.6-7.9] | <0.01 |
| -No (n = 323) | 269 (83.3%) | 1 | | | |
| Severe anaemia | | | | | |
| -Yes (n = 95) | 14 (14.7%) | 1.7[0.8-3.3] | <0.13 | 1.8[0.8-4.2] | 0.1 |
| -No (n = 323) | 30 (9.3%) | 1 | | | |
| BCS ≤ 2 | | | | | |
| -Yes (n = 95) | 2 (2.1%) | --- | --- | | |
| -No (n = 323) | 0 (0.0%° | -- | --- | | |
| Thrombopenia | | | | | |
| -Yes (n = 95) | 80 (84.2%) | 19.6[10.6-36.2] | <0.01 | 2.6[1.3-5.3] | <0.01 |
| -No (n = 323) | 69 (21.4%) | 1 | | | |
| VOC | | | | | |
| -Yes (n = 95) | 2 (2.1%) | 0.2[0.02-0.7] | <0.01 | 0.1[0.0-0.5] | <0.01 |
| -No (n = 323) | 35 (10.8%) | 1 |
a: crude odds ratio; b: 95% confidence interval; c: adjusted odds ratio d: malaria infected patients; e: non infected patients;
f: see detailed symptoms in Table 1, g : vaso-occlusive crisis in patients with sickle cell disease.
Drug prescription for patients (n = 418) with positive or negative slides at CHL
| 1 (0.4) | 59 (62.1) | 43 (58.9) | 103 (24.6) | |
| 188 (75.2) | 0 (0.0) | 0 (0.0) | 188 (44.9) | |
| 9 (3.6) | 36 (37.9) | 28 (38.4) | 73 (17.5) | |
| 52 (20.8) | 0 (0.0) | 2 (2.7) | 52 (20.8) | |